About DAVA Pharmaceuticals
DAVA Pharmaceuticals is a Healthcare company based in Fort Lee (United States) founded in 2004, and was acquired by Endo International in June 2014. Generic drugs are manufactured and distributed by DAVA Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals.
Company details
DAVA Pharmaceuticals was founded in 2004 and is based in Fort Lee, United States. Operations are centered on the pharmaceutical sector, where generic drugs are produced to serve healthcare needs. Manufacturing activities are conducted to ensure compliance with industry standards, and the companys domain, davapharma.com, supports its digital operations. Focus remains on providing essential medications across domestic markets.
- Headquarters Fort Lee, United States
- Stage Acquired
- SectorsHealthcare
- Website davapharma.com
- Acquired by Endo International (Jun 2014)
- Investors
- Acquired byEndo International
(Jun 2014)
Investors in DAVA Pharmaceuticals
DAVA Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Endo International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines | 1997 | endo.com | Malvern, United States |
Investor details for DAVA Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of DAVA Pharmaceuticals
2 dated milestones of DAVA Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.
- Founded DAVA Pharmaceuticals is founded.
- Exit Acquired by Endo International.
Web traffic of DAVA Pharmaceuticals
Websites that share an audience with DAVA Pharmaceuticals (davapharma.com).
Websites whose visitors overlap most with DAVA Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| palmettopharm.com | 100% | 1.3K | #11,520,260 | View details | |
nucarerx.com | nucarerx.com | 99% | #10,661,435 | β |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as DAVA Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DAVA Pharmaceuticals
DAVA Pharmaceuticals was founded in 2004.
DAVA Pharmaceuticals is headquartered in Fort Lee, United States. It is registered at Fort Lee, New Jersey, United States.
DAVA Pharmaceuticals was founded in 2004 and is based in Fort Lee, United States. Operations are centered on the pharmaceutical sector, where generic drugs are produced to serve healthcare needs. Manufacturing activities are conducted to ensure compliance with industry standards, and the companys domain, davapharma.com, supports its digital operations. Focus remains on providing essential medications across domestic markets.
DAVA Pharmaceuticals has 1 investor. Key investors include Endo International.
Yes. DAVA Pharmaceuticals was acquired by Endo International in June 2014.
